Early major adverse cardiovascular events following the initiation of the anti-interleukin 12/23 antibody ustekinumab. A population-based case-time-control study

Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02303760
Contributor : Laurent Jonchère <>
Submitted on : Wednesday, October 2, 2019 - 3:31:44 PM
Last modification on : Friday, October 4, 2019 - 1:07:37 AM

Links full text

Identifiers

Citation

F. Poizeau, E. Nowak, S. Kerbrat, C. Droitcourt, E. Sbidian, et al.. Early major adverse cardiovascular events following the initiation of the anti-interleukin 12/23 antibody ustekinumab. A population-based case-time-control study. Journal of Investigative Dermatology, Nature Publishing Group, 2019, 139 (9), pp.S230-S230. ⟨10.1016/j.jid.2019.07.097⟩. ⟨hal-02303760⟩

Share

Metrics

Record views

27